Discuss This Drug

TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)

CHEBI:CHEBI_753058

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1726680
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
dosage_form
INJECTION
route
INTRAMUSCULAR
pharm_class
Emesis Suppression [PE]
marketing_start_date
20200110
package_marketing_start_date
20221211
active_ingredient_strength
100 mg/mL
labeler_name
HF Acquisition Co LLC, DBA HealthFirst
manufacturer_name
HF Acquisition Co LLC, DBA HealthFirst
active_ingredient_name
TRIMETHOBENZAMIDE HYDROCHLORIDE
unii
WDQ5P1SX7Q
application_number
NDA017530
generic_name
TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)
brand_name
TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)
brand_name_base
TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)
product_ndc
51662-1430
spl_id
0ffba8c5-bf5e-a665-e063-6294a90a64f6
package_ndc
51662-1430-3
package_description
25 POUCH in 1 CASE (51662-1430-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1430-2) / 2 mL in 1 VIAL, SINGLE-DOSE
spl_set_id
9bd0bfa0-c189-751c-e053-2a95a90a5f5a
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class